Genetic Medicine of African Populations (GeneMAP) is an innovative research centre based at the University of Cape Town under the directorship of Prof. Ambroise Wonkam. Since its launch in 2018, GeneMAP has become a leader in genomics and genetic research on the African continent, focusing on conditions such as sickle cell disease, hearing loss, Fragile-X syndrome, and addressing key ethical, legal, and social issues. African populations have been vastly understudied in genomic research, as evidenced by the lack of genomic data on these populations. GeneMAP seeks to address this inequity by studying African genomes, contributing to a global understanding of human genetic diversity.
The research centre plays a pivotal role in advancing genomic medicine, with a focus on developing diagnostic tools and treatments tailored to the unique genetic architecture of African populations. Africa is home to the largest diversity in human genomes and contains some of the most ancient human genome sequences. By studying African genomes, GeneMAP not only aims to improve healthcare outcomes for African populations but also contributes valuable insights that can benefit global health.
In addition to its research, GeneMAP trains the next generation of genetic researchers, builds research capacity, and supports African-led research initiatives. Through its multi-disciplinary programs, the research centre advocates for policies that promote the inclusion of African genetic data in global genomic studies. By addressing these gaps, GeneMAP is helping to ensure that African populations are represented in the evolving field of genomics, with the potential for significant global impact in the study of human genetics and medicine.
Visit the GeneMAP website for more information.